Healio: Interim results show AB-101a significantly controls atopic dermatitis skin bacteria
by Gabrielle Capaldo
80% of patients achieved an itch score improvement of 4 points or more.
90% of patients achieved EASI 50 and 44% achieved EASI 75.
CONTACTS
Corporate:
Neal Koller
nkoller@alphynbiologics.com
(410) 690-8687
Media:
Susan Thomas
susan@endpointcommunications.net
(619) 540-9195